Thanks to a breakthrough medication injected every two months, people living with HIV in Scotland will soon be free of the burden of taking daily medicines. Trials combining the antiretroviral medicines cabotegravir and rilpivirine demonstrated they work as well as daily pills in combating the incurable virus that assaults the immune system, prompting health officials to approve the vaccine. Researchers discovered that nine out of ten individuals who take this medication achieve 'undetectable viral load,' which is the aim of HIV treatment and implies a patient not only stays healthy but also has such little levels of the virus in their body that they cannot transmit it on to others.
Reducing the stress of taking medicines on a daily basis may lessen the emotional toll of HIV, while making it easier may increase the percentage of people who continue to their treatment plan. Medication is essential for avoiding HIV's cumulative harm, which includes opportunistic infections, illnesses, and a diagnosis of AIDS, which is deadly. It is an amazing step forward, according to Nneka Nwokolo, honorary consultant physician in HIV and sexual health at Chelsea and Westminster Hospital NHS Foundation Trust in West London and senior global medical director of ViiV Healthcare, which develops the new therapy. 'It's a significant step forward for those living with HIV because it gives them more options,' she added. 'Many HIV patients struggle to take their medication on a daily basis for a variety of reasons.
Serious adverse effects were uncommon, and 91 percent of patients preferred the long-acting injectable over daily pills, according to research. Antiretroviral therapy (ART) is a type of treatment that inhibits the virus that assaults the immune system. Antiretroviral treatment, which was originally administered as a daily pill, changed the perspective and life expectancy of HIV patients. The virus is tough to cure, and it was formerly thought to be a death sentence when it was first discovered in the 1980s.
When the virus, which is spread by blood and other bodily fluids, enters the body, it infects cells by combining its genetic material with human DNA. This results in a mutant cell that, in minutes, throws forth hundreds of copies of itself, essentially undetected by the immune system. Because viral copies change so quickly as a result of this process, targeted therapies or vaccinations quickly become ineffective. ART, on the other hand, can attack the virus at various stages of its life cycle, preventing it from infecting cells, changing quickly, and spreading throughout the body. Cabotegravir inhibits a key step in HIV replication inside infected cells, lowering HIV levels in the blood. One has to wonder how long will this take before it's finally introduced in South Africa.
Content created and supplied by: News.info20 (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More